Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Paul Bunn to Lymphoma

This is a "connection" page, showing publications Paul Bunn has written about Lymphoma.

 
Connection Strength
 
 
 
1.302
 
  1. Bunn PA. Diagnostic factors in intermediate and high-grade lymphomas: pathologic, immunologic, and clinical. J Clin Oncol. 1988 Jul; 6(7):1073-5.
    View in: PubMed
    Score: 0.070
  2. Foon KA, Roth MS, Bunn PA. Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemia. Semin Oncol. 1986 Sep; 13(3 Suppl 2):35-42.
    View in: PubMed
    Score: 0.062
  3. Bunn PA, Ihde DC, Foon KA. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas. Cancer. 1986 Apr 15; 57(8 Suppl):1689-95.
    View in: PubMed
    Score: 0.060
  4. Boven E, Lindmo T, Mitchell JB, Bunn PA. Selective cytotoxicity of 125I-labeled monoclonal antibody T101 in human malignant T cell lines. Blood. 1986 Feb; 67(2):429-35.
    View in: PubMed
    Score: 0.060
  5. Foon KA, Schroff RW, Bunn PA. Clinical applications of monoclonal antibodies for patients with leukemia and lymphoma. Prog Clin Biol Res. 1986; 211:265-84.
    View in: PubMed
    Score: 0.059
  6. Bunn PA, Foon KA. Therapeutic options in advanced cutaneous T cell lymphomas: a role for interferon alfa-2a (Roferon-A). Semin Oncol. 1985 Dec; 12(4 Suppl 5):18-24.
    View in: PubMed
    Score: 0.059
  7. Bertness V, Kirsch I, Hollis G, Johnson B, Bunn PA. T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N Engl J Med. 1985 Aug 29; 313(9):534-8.
    View in: PubMed
    Score: 0.058
  8. Rosen ST, Radvany R, Roenigk H, Terasaki PI, Bunn PA. Human leukocyte antigens in cutaneous T cell lymphoma. J Am Acad Dermatol. 1985 Mar; 12(3):531-4.
    View in: PubMed
    Score: 0.056
  9. Bunn PA, Carrasquillo JA, Keenan AM, Schroff RW, Foon KA, Hsu SM, Gazdar AF, Reynolds JC, Perentesis P, Larson SM. Imaging of T-cell lymphoma by radiolabelled monoclonal antibody. Lancet. 1984 Nov 24; 2(8413):1219-21.
    View in: PubMed
    Score: 0.055
  10. Bunn PA, Foon KA, Ihde DC, Longo DL, Eddy J, Winkler CF, Veach SR, Zeffren J, Sherwin S, Oldham R. Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med. 1984 Oct; 101(4):484-7.
    View in: PubMed
    Score: 0.054
  11. Bunn PA, Schechter GP, Jaffe E, Blayney D, Young RC, Matthews MJ, Blattner W, Broder S, Robert-Guroff M, Gallo RC. Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N Engl J Med. 1983 Aug 04; 309(5):257-64.
    View in: PubMed
    Score: 0.050
  12. Winkler CF, Bunn PA. Cutaneous T-cell lymphoma: a review. Crit Rev Oncol Hematol. 1983; 1(1):49-92.
    View in: PubMed
    Score: 0.048
  13. Posner LE, Fossieck BE, Eddy JL, Bunn PA. Septicemic complications of the cutaneous T-cell lymphomas. Am J Med. 1981 Aug; 71(2):210-6.
    View in: PubMed
    Score: 0.044
  14. Broder S, Bunn PA. Cutaneous T-cell lymphomas. Semin Oncol. 1980 Sep; 7(3):310-31.
    View in: PubMed
    Score: 0.041
  15. Bunn PA, Huberman MS, Whang-Peng J, Schechter GP, Guccion JG, Matthews MJ, Gazdar AF, Dunnick NR, Fischmann AB, Ihde DC, Cohen MH, Fossieck B, Minna JD. Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination. Ann Intern Med. 1980 Aug; 93(2):223-30.
    View in: PubMed
    Score: 0.041
  16. Bunn PA, Carney DN. Treatment of cutaneous T-cell lymphoma. J Dermatol Surg Oncol. 1980 May; 6(5):383-7.
    View in: PubMed
    Score: 0.040
  17. Carney DN, Bunn PA. Manifestations of cutaneous T-cell lymphoma. J Dermatol Surg Oncol. 1980 May; 6(5):369-77.
    View in: PubMed
    Score: 0.040
  18. Lamberg SI, Bunn PA. Cutaneous T-cell lymphomas. Summary of the Mycosis Fungoides Cooperative Group-National Cancer Institute Workshop. Arch Dermatol. 1979 Sep; 115(9):1103-5.
    View in: PubMed
    Score: 0.038
  19. Bunn PA, Schein PS, Banks PM, DeVita VT. Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited. Blood. 1976 Jan; 47(1):3-10.
    View in: PubMed
    Score: 0.030
  20. Mulshine JL, Carrasquillo JA, Weinstein JN, Keenan AM, Reynolds JC, Herdt J, Bunn PA, Sausville E, Eddy J, Cotelingam JD, et al. Direct intralymphatic injection of radiolabeled 111In-T101 in patients with cutaneous T-cell lymphoma. Cancer Res. 1991 Jan 15; 51(2):688-95.
    View in: PubMed
    Score: 0.021
  21. Keenan AM, Weinstein JN, Carrasquillo JA, Bunn PA, Reynolds JC, Foon KA, Smarte NC, Ghosh B, Fejka RM, Larson SM, et al. Immunolymphoscintigraphy and the dose dependence of 111In-labeled T101 monoclonal antibody in patients with cutaneous T-cell lymphoma. Cancer Res. 1987 Nov 15; 47(22):6093-9.
    View in: PubMed
    Score: 0.017
  22. Carrasquillo JA, Mulshine JL, Bunn PA, Reynolds JC, Foon KA, Schroff RW, Perentesis P, Steis RG, Keenan AM, Horowitz M, et al. Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphoma. J Nucl Med. 1987 Mar; 28(3):281-7.
    View in: PubMed
    Score: 0.016
  23. Keenan AM, Weinstein JN, Mulshine JL, Carrasquillo JA, Bunn PA, Reynolds JC, Larson SM. Immunolymphoscintigraphy in patients with lymphoma after subcutaneous injection of indium-111-labeled T101 monoclonal antibody. J Nucl Med. 1987 Jan; 28(1):42-6.
    View in: PubMed
    Score: 0.016
  24. Carrasquillo JA, Bunn PA, Keenan AM, Reynolds JC, Schroff RW, Foon KA, Su MH, Gazdar AF, Mulshine JL, Oldham RK, et al. Radioimmunodetection of cutaneous T-cell lymphoma with 111In-labeled T101 monoclonal antibody. N Engl J Med. 1986 Sep 11; 315(11):673-80.
    View in: PubMed
    Score: 0.016
  25. Sausville EA, Worsham GF, Matthews MJ, Makuch RW, Fischmann AB, Schechter GP, Gazdar AF, Bunn PA. Histologic assessment of lymph nodes in mycosis fungoides/S?zary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system. Hum Pathol. 1985 Nov; 16(11):1098-109.
    View in: PubMed
    Score: 0.015
  26. Whang-Peng J, Bunn PA, Knutsen T, Kao-Shan CS, Broder S, Jaffe ES, Gelmann E, Blattner W, Lofters W, Young RC, et al. Cytogenetic studies in human T-cell lymphoma virus (HTLV)-positive leukemia-lymphoma in the United States. J Natl Cancer Inst. 1985 Feb; 74(2):357-69.
    View in: PubMed
    Score: 0.014
  27. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods. 1984 Aug 03; 72(1):77-89.
    View in: PubMed
    Score: 0.013
  28. Jaffe ES, Blattner WA, Blayney DW, Bunn PA, Cossman J, Robert-Guroff M, Gallo RC. The pathologic spectrum of adult T-cell leukemia/lymphoma in the United States. Human T-cell leukemia/lymphoma virus-associated lymphoid malignancies. Am J Surg Pathol. 1984 Apr; 8(4):263-75.
    View in: PubMed
    Score: 0.013
  29. Sch?pbach J, Kalyanaraman VS, Sarngadharan MG, Bunn PA, Blayney DW, Gallo RC. Demonstration of viral antigen p24 in circulating immune complexes of two patients with human T-cell leukaemia/lymphoma virus (HTLV) positive lymphoma. Lancet. 1984 Feb 11; 1(8372):302-5.
    View in: PubMed
    Score: 0.013
  30. Mitsuya H, Matis LA, Megson M, Bunn PA, Murray C, Mann DL, Gallo RC, Broder S. Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus. J Exp Med. 1983 Sep 01; 158(3):994-9.
    View in: PubMed
    Score: 0.013
  31. Blayney DW, Blattner WA, Robert-Guroff M, Jaffe ES, Fisher RI, Bunn PA, Patton MG, Rarick HR, Gallo RC. The human T-cell leukemia-lymphoma virus in the southeastern United States. JAMA. 1983 Aug 26; 250(8):1048-52.
    View in: PubMed
    Score: 0.013
  32. Blayney DW, Jaffe ES, Blattner WA, Cossman J, Robert-Guroff M, Longo DL, Bunn PA, Gallo RC. The human T-cell leukemia/lymphoma virus associated with American adult T-cell leukemia/lymphoma. Blood. 1983 Aug; 62(2):401-5.
    View in: PubMed
    Score: 0.013
  33. Gallo RC, Kalyanaraman VS, Sarngadharan MG, Sliski A, Vonderheid EC, Maeda M, Nakao Y, Yamada K, Ito Y, Gutensohn N, Murphy S, Bunn PA, Catovsky D, Greaves MF, Blayney DW, Blattner W, Jarrett WF, zur Hausen H, Seligmann M, Brouet JC, Haynes BF, Jegasothy BV, Jaffe E, Cossman J, Broder S, Fisher RI, Golde DW, Robert-Guroff M. Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res. 1983 Aug; 43(8):3892-9.
    View in: PubMed
    Score: 0.013
  34. Robert-Guroff M, Kalyanaraman VS, Blattner WA, Popovic M, Sarngadharan MG, Maeda M, Blayney D, Catovsky D, Bunn PA, Shibata A, Nakao Y, Ito Y, Aoki T, Gallo RC. Evidence for human T cell lymphoma-leukemia virus infection of family members of human T cell lymphoma-leukemia virus positive T cell leukemia-lymphoma patients. J Exp Med. 1983 Jan 01; 157(1):248-58.
    View in: PubMed
    Score: 0.012
  35. Whang-Peng J, Bunn PA, Knutsen T, Matthews MJ, Schechter G, Minna JD. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer. 1982 Oct 15; 50(8):1539-53.
    View in: PubMed
    Score: 0.012
  36. Blatt J, Bunn PA, Carney DD, Reaman G, Soprey P, Poplack DG. Purine pathway enzymes in the circulating malignant cells of patients with cutaneous T-cell lymphoma. Br J Haematol. 1982 Sep; 52(1):97-104.
    View in: PubMed
    Score: 0.012
  37. Kalyanaraman VS, Sarngadharan MG, Bunn PA, Minna JD, Gallo RC. Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus. Nature. 1981 Nov 19; 294(5838):271-3.
    View in: PubMed
    Score: 0.011
  38. Posner LE, Robert-Guroff M, Kalyanaraman VS, Poiesz BJ, Ruscetti FW, Fossieck B, Bunn PA, Minna JD, Gallo RC. Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas. J Exp Med. 1981 Aug 01; 154(2):333-46.
    View in: PubMed
    Score: 0.011
  39. BALTCH AL, HASSIRDJIAN A, OSBORNE W, BUNN PA. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs. J Lab Clin Med. 1961 Mar; 57:420-7.
    View in: PubMed
    Score: 0.011
  40. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec; 77(12):7415-9.
    View in: PubMed
    Score: 0.010
  41. Carney DN, Bunn PA, Schechter GP, Gazdar AF. Lymphocyte transformation in patients with cutaneous T-cell lymphomas. Int J Cancer. 1980 Nov 15; 26(5):535-42.
    View in: PubMed
    Score: 0.010
  42. Myrie C, Bunn PA, Edelson RL. A clinico-histopathologic atlas. J Dermatol Surg Oncol. 1980 May; 6(5):391-400.
    View in: PubMed
    Score: 0.010
  43. Huberman MS, Bunn PA, Matthews MJ, Ihde DC, Gazdar AF, Cohen MH, Minna JD. Hepatic involvement in the cutaneous T-cell lymphomas: results of percutaneous biopsy and peritoneoscopy. Cancer. 1980 Apr 01; 45(7):1683-8.
    View in: PubMed
    Score: 0.010
  44. Gazdar AF, Carney DN, Bunn PA, Russell EK, Jaffe ES, Schechter GP, Guccion JG. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood. 1980 Mar; 55(3):409-17.
    View in: PubMed
    Score: 0.010
  45. Radice PA, Bunn PA, Ihde DC. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies. Cancer Treat Rep. 1979 Aug; 63(8):1231-9.
    View in: PubMed
    Score: 0.009
  46. Broder S, Bunn PA, Jaffe ES, Blattner W, Gallo RC, Wong-Staal F, Waldmann TA, DeVita VT. NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. Ann Intern Med. 1984 Apr; 100(4):543-57.
    View in: PubMed
    Score: 0.003
  47. BALTCH AL, OSBORNE W, BUNN PA, CANARILE L, HASSIRDJIAN A. Serum complement and bacteriophage neutralization titers in human infections, leukemias, and lymphomas. J Lab Clin Med. 1960 Oct; 56:594-606.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)